Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B 1.1.7 variant of SARS-CoV-2

J Travel Med. 2021 Mar 27;taab051. doi: 10.1093/jtm/taab051. Online ahead of print.
No abstract available

Keywords: N501Y; SARS-CoV-2; escape mutants, vaccine efficacy; neutralization; variant of concern.